Related Experiment Video
Updated: Aug 6, 2026
09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Drug-induced thrombocytopenia: a population study
Maarten J ten Berg1, Albert Huisman, Patrick C Souverein
1Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.
Drug Safety
|July 29, 2006
Summary
Beta-lactam antibacterials significantly increase the risk of drug-induced immune thrombocytopenia. Other common drugs like DMARDs and sulfonamides showed no confirmed risk, requiring further investigation.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Epidemiology
Background:
- Drug-induced immune thrombocytopenia (DITP) is a rare adverse drug reaction.
- Existing data on DITP frequency and risk factors primarily comes from case reports.
- This study quantifies DITP risk associated with commonly implicated drugs.
Purpose of the Study:
- To assess the risk of thrombocytopenia associated with specific drug classes.
- To investigate drugs frequently reported to cause thrombocytopenia in the general population.
Main Methods:
- Retrospective case-control study using the PHARMO record linkage system (1990-2002).
- 705 cases of thrombocytopenia were matched with up to 4 controls each.
- Multivariate conditional logistic regression analyzed exposure to anticonvulsants, beta-lactams, DMARDs, NSAIDs, sulfonamides, etc.
Main Results:
- Current use of beta-lactam antibacterials showed a significant increase in thrombocytopenia risk (aOR 7.4).
- DMARDs and cotrimoxazole (trimethoprim/sulfamethoxazole) showed non-significant increased risk estimates.
- No increased risk was observed for anticonvulsants, cinchona alkaloids, diuretics, NSAIDs, or tuberculostatics.
Conclusions:
- This study provides evidence for an increased risk of thrombocytopenia with beta-lactam antibacterial use.
- The lack of confirmed risk for other drugs may be due to limited statistical power.
- Further research with larger patient cohorts and laboratory data is recommended to confirm findings.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...